Search

Search Constraints

You searched for: Author/Creator Lecaille, Cedric

Search Results

1. Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study. Issue 2 (February 2021)

2. Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized multicentre trial. (10th March 2021)

3. Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49. Issue 3 (March 2022)

4. Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study. Issue 1 (13th February 2020)

5. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. (September 2017)

6. Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study. Issue 3 (March 2019)